|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
5/22/2013
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-36
|
$47.52
|
-100.00%
|
|
5/22/2013
|
NOTEBAERT RICHARD C
|
Director
|
-3,197
|
$48.10
|
-9.31%
|
|
5/22/2013
|
NOTEBAERT RICHARD C
|
Director
|
3,254
|
$46.49
|
10.47%
|
|
5/20/2013
|
SPAULDING JEAN G
|
Director
|
-1,666
|
$47.90
|
-8.93%
|
|
5/20/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-45,994
|
$48.00
|
-32.55%
|
|
5/20/2013
|
WATKINS CAROLE S
|
Chief HR Officer
|
6,494
|
$22.90
|
15.58%
|
|
5/20/2013
|
WATKINS CAROLE S
|
Chief HR Officer
|
-4,612
|
$48.00
|
-9.57%
|
|
5/20/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
60,441
|
$27.29
|
74.73%
|
|
5/14/2013
|
COX CARRIE SMITH
|
Director
|
435
|
$46.25
|
3.18%
|
|
5/8/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
30,221
|
$27.29
|
39.64%
|
|
5/8/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-24,070
|
$46.19
|
-22.61%
|
|
5/7/2013
|
WATKINS CAROLE S
|
Chief HR Officer
|
-25,592
|
$45.95
|
-38.04%
|
|
5/7/2013
|
WATKINS CAROLE S
|
Chief HR Officer
|
5,284
|
$22.90
|
8.52%
|
|
5/7/2013
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
38,350
|
$27.91
|
213.59%
|
|
5/7/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
30,221
|
$27.29
|
43.12%
|
|
5/7/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-24,070
|
$46.06
|
-24.00%
|
|
5/7/2013
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-30,825
|
$46.00
|
-54.75%
|
|
5/6/2013
|
NOTEBAERT RICHARD C
|
Director
|
2,205
|
$43.21
|
7.09%
|
|
5/6/2013
|
SPAULDING JEAN G
|
Director
|
2,401
|
$39.69
|
8.99%
|
|
5/6/2013
|
SPAULDING JEAN G
|
Director
|
3,044
|
$39.69
|
12.86%
|
|
5/6/2013
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-14,253
|
$46.14
|
-26.48%
|
|
5/6/2013
|
NOTEBAERT RICHARD C
|
Director
|
-5,001
|
$46.25
|
-13.86%
|
|
5/6/2013
|
Henderson Jeffrey William
|
Chief Financial Officer
|
98,895
|
$41.10
|
89.98%
|
|
5/6/2013
|
NOTEBAERT RICHARD C
|
Director
|
2,796
|
$43.21
|
8.40%
|
|
5/6/2013
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-207,918
|
$46.18
|
-65.91%
|
|
5/6/2013
|
SPAULDING JEAN G
|
Director
|
-10,447
|
$46.19
|
-35.89%
|
|
5/6/2013
|
Henderson Jeffrey William
|
Chief Financial Officer
|
106,636
|
$27.29
|
51.07%
|
|
5/6/2013
|
SPAULDING JEAN G
|
Director
|
5,002
|
$43.21
|
26.80%
|
|
4/16/2013
|
Casey Donald M Jr.
|
CEO, Medical Segment
|
-249
|
$43.01
|
-0.83%
|
|
1/23/2013
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-58,362
|
$44.95
|
-35.87%
|
|
1/23/2013
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
55,158
|
$27.29
|
51.29%
|
|
1/23/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-47,274
|
$45.00
|
-40.28%
|
|
1/23/2013
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-39,080
|
$45.00
|
-42.06%
|
|
1/23/2013
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
60,441
|
$27.29
|
106.18%
|
|
1/23/2013
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
49,965
|
$27.29
|
116.35%
|
|
1/14/2013
|
WATKINS CAROLE S
|
Chief HR Officer
|
643
|
$22.90
|
1.02%
|
|
1/14/2013
|
WATKINS CAROLE S
|
Chief HR Officer
|
-509
|
$43.06
|
-0.80%
|
|
1/10/2013
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
49,965
|
$27.29
|
152.11%
|
|
1/10/2013
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-1,471
|
$42.92
|
-7.57%
|
|
1/10/2013
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-39,867
|
$43.00
|
-48.14%
|
|
12/14/2012
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-2,330
|
$42.25
|
-10.71%
|
|
11/1/2012
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-2,564
|
$41.22
|
-33.24%
|
|
10/15/2012
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-1,095
|
$40.89
|
-4.79%
|
|
10/4/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
50,000
|
$27.29
|
47.11%
|
|
10/4/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-46,226
|
$40.00
|
-29.61%
|
|
9/15/2012
|
WATKINS CAROLE S
|
Chief HR Officer
|
-1,291
|
$38.37
|
-2.01%
|
|
9/15/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-4,143
|
$38.37
|
-3.76%
|
|
9/15/2012
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-210
|
$38.37
|
-0.37%
|
|
9/15/2012
|
Barrett George S
|
Chairman and CEO
|
-21,881
|
$38.37
|
-5.63%
|
|
9/15/2012
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-763
|
$38.37
|
-2.27%
|
|
9/15/2012
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-382
|
$38.37
|
-0.35%
|
|
9/15/2012
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-306
|
$38.37
|
-3.82%
|
|
9/10/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
50,000
|
$27.29
|
36.40%
|
|
9/10/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-77,081
|
$38.29
|
-41.14%
|
|
9/7/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-2,329
|
$39.39
|
-100.00%
|
|
8/16/2012
|
WATKINS CAROLE S
|
Chief HR Officer
|
-1,139
|
$38.81
|
-1.74%
|
|
8/16/2012
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-185
|
$39.81
|
-0.32%
|
|
8/16/2012
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-349
|
$39.81
|
-0.32%
|
|
8/16/2012
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-692
|
$39.81
|
-2.94%
|
|
8/16/2012
|
Barrett George S
|
Chairman and CEO
|
-11,037
|
$39.81
|
-2.76%
|
|
8/16/2012
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-103
|
$39.81
|
-0.31%
|
|
8/16/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-2,783
|
$39.81
|
-1.99%
|
|
8/16/2012
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-270
|
$39.81
|
-3.26%
|
|
8/15/2012
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-2,002
|
$39.77
|
-1.81%
|
|
8/15/2012
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-528
|
$39.77
|
-2.19%
|
|
8/15/2012
|
Barrett George S
|
Chairman and CEO
|
-6,827
|
$39.77
|
-1.68%
|
|
8/15/2012
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-2,231
|
$39.77
|
-1.57%
|
|
8/15/2012
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-139
|
$39.77
|
-0.24%
|
|
8/15/2012
|
WATKINS CAROLE S
|
Chief HR Officer
|
-830
|
$39.77
|
-1.25%
|
|
8/15/2012
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-84
|
$39.77
|
-0.25%
|
|
8/15/2012
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-196
|
$39.77
|
-2.31%
|
|
5/17/2012
|
SPAULDING JEAN G
|
Director
|
-8,135
|
$42.06
|
-34.78%
|
|
5/17/2012
|
SPAULDING JEAN G
|
Director
|
9,801
|
$28.80
|
72.12%
|
|
2/27/2012
|
Lynch Michael A
|
CEO, Medical Segment
|
-31,373
|
$42.00
|
-26.02%
|
|
2/27/2012
|
Lynch Michael A
|
CEO, Medical Segment
|
39,400
|
$27.29
|
48.54%
|
|
2/24/2012
|
Lynch Michael A
|
CEO, Medical Segment
|
-40,173
|
$41.59
|
-33.11%
|
|
2/24/2012
|
Lynch Michael A
|
CEO, Medical Segment
|
31,941
|
$32.33
|
35.72%
|
|
2/24/2012
|
Lynch Michael A
|
CEO, Medical Segment
|
232
|
$22.90
|
0.26%
|
|
10/27/2011
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
53,158
|
$27.29
|
67.59%
|
|
10/27/2011
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-41,164
|
$44.95
|
-31.23%
|
|
10/26/2011
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-2,000
|
$44.95
|
-2.48%
|
|
10/26/2011
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
2,000
|
$27.29
|
2.54%
|
|
10/19/2011
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-1,341
|
$42.40
|
-17.34%
|
|
10/15/2011
|
Blake Mark R
|
EVP - Strategy & Corp. Dev.
|
-1,095
|
$42.09
|
-5.49%
|
|
9/15/2011
|
Lynch Michael A
|
CEO, Medical Segment
|
-3,017
|
$41.58
|
-3.27%
|
|
9/15/2011
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-305
|
$41.58
|
-3.79%
|
|
9/15/2011
|
Morford Craig S
|
Chief Legal/Compliance Officer
|
-210
|
$41.58
|
-0.45%
|
|
9/15/2011
|
Barrett George S
|
Chairman and CEO
|
-21,880
|
$41.58
|
-6.10%
|
|
9/15/2011
|
WATKINS CAROLE S
|
Chief HR Officer
|
-1,593
|
$41.58
|
-2.70%
|
|
9/15/2011
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-444
|
$41.58
|
-0.56%
|
|
9/15/2011
|
Henderson Jeffrey William
|
Chief Financial Officer
|
-4,143
|
$41.58
|
-3.30%
|
|
9/15/2011
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-763
|
$41.58
|
-2.63%
|
|
9/14/2011
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-1,191
|
$41.14
|
-12.90%
|
|
8/17/2011
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-1,100
|
$41.73
|
-10.65%
|
|
8/16/2011
|
Stephen Falk T
|
EVP, Gen. Counsel & Corp. Sec.
|
-103
|
$41.60
|
-0.35%
|
|
8/16/2011
|
LAWS STUART G
|
SVP & Chief Accounting Officer
|
-269
|
$41.60
|
-2.54%
|
|
8/16/2011
|
Lynch Michael A
|
CEO, Medical Segment
|
-2,349
|
$41.60
|
-2.48%
|
|
8/16/2011
|
Kaufmann Michael C
|
CEO, Pharmaceutical Segment
|
-405
|
$41.60
|
-0.51%
|
|
8/16/2011
|
WATKINS CAROLE S
|
Chief HR Officer
|
-1,139
|
$41.60
|
-1.89%
|
|
8/16/2011
|
Barrett George S
|
Chairman and CEO
|
-11,390
|
$41.60
|
-3.08%
|